Delivery Order SPE2DX15D8002-SPE2DX24F2UL2
Award Date 1/9/24
Potential Completion Date 1/31/24
Potential Value $3.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,231.24 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC), valued at $999,999,999.00, with the DLA as part of the ECAT Generation V...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, identified as SPE2DB24D8001, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract...
- The federal government awarded a firm-fixed-price delivery order contract worth $3,511.46 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of PROQUAD VIALS. This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical division, a component of the Department of Defense, and has an ultimate completion date of March 24, 2023. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment...
- The federal contract award SPE2DX15D8002|SPE2DX24F2TS8, valued at $2,818.10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a firm fixed-price delivery order for the provision of PROQUAD VIALS, a pharmaceutical product. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is valued at $1,755.73 and covers the delivery of PROQUAD VIALS, a type of pharmaceutical product, to support military medical operations. The contract is not set aside and is awarded under Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) with the DLA,...
- This is a firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is valued at $5,770.10 and has a period of performance through June 25, 2024. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, to support the medical supply chain operations of the U.S. Armed Forces. The contract was awarded without a set-aside designation, indicating...
- This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZHK, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of PROQUAD VIALS, which are likely pharmaceutical products or medical supplies. It is a firm fixed-price delivery order contract with a ceiling value of $1,836.34 and a period of performance extending to March 26, 2025. Dakota Drug, Inc. holds a significant...
- This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The contract is a delivery order valued at $1,839.89 with a firm fixed price. It is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a period of performance ending on January 27, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001 and valued at $999,999,999.00. This IDC is part...
- This federal contract award, identified as SPE2DX15D8001|SPE2DX23FBRJG, was issued by the Defense Logistics Agency's Medical Supply Chain division to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,755.73 firm fixed-price delivery order is for the provision of PROQUAD VIALS, a pharmaceutical product, with a performance period ending on October 11, 2023. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $7,359.56, is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a period of performance through August 1, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which is part of the DLA Troop Support...